Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3703-3709, July 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glebov, O. K.
Right arrow Articles by Sukumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glebov, O. K.
Right arrow Articles by Sukumar, S.

Frequent p53 Gene Mutations and Novel Alleles in Familial Breast Cancer1

Oleg K. Glebov, Katherine E. McKenzie, Christine A. White and Saraswati Sukumar2

Salk Institute for Biological Studies, La Jolla, California 92037 [O. K. G., K. E. M., C. A. W., S. S.]; Scripps Memorial Hospitals Oncology Research Program, Encinitas, CA 92023 [C. A. W.]

Mutations in the p53 gene were detected in 58% of tumor DNAs of patients with a family history of breast cancer (FHBC) compared to 13% with sporadic breast cancer. Seven of 18 FHBC tumors contained the same G to C transversion in codon 156. Novel alleles of altered length were seen in one or more loci on chromosome 17 in 15 of 18 patients with FHBC but only in a single locus in 8 of 14 patients with sporadic breast cancer. The frequency of tumors with mutations in p53, often multiple, accompanied by the appearance of multiple altered-length alleles suggest that DNA replication or repair defects may presage genomic instability in cases with FHBC.

1 This work was supported by USPHS Grants CA48943, CA57993, and ESO06094 and grants from the Foundation of Medical Research, Inc. (to S. S.).

2 To whom requests for reprints should be addressed, at Salk Institute for Biological Studies, Molecular Biology of Breast Cancer Laboratory, 10010 N. Torrey Pines Rd., La Jolla, CA 92037.

Received 4/19/94. Accepted 5/26/94.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
P Vahteristo, S Ojala, A Tamminen, J Tommiska, H Sammalkorpi, S Kiuru-Kuhlefelt, H Eerola, L A Aaltonen, K Aittomaki, and H Nevanlinna
No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer
J. Med. Genet., April 1, 2005; 42(4): e22 - e22.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Ashur-Fabian, A. Avivi, L. Trakhtenbrot, K. Adamsky, M. Cohen, G. Kajakaro, A. Joel, N. Amariglio, E. Nevo, and G. Rechavi
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
PNAS, August 17, 2004; 101(33): 12236 - 12241.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. E. Buller, T. A. Lallas, M. S. Shahin, A. K. Sood, M. Hatterman-Zogg, B. Anderson, J. I. Sorosky, and P. A. Kirby
The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer
Clin. Cancer Res., April 1, 2001; 7(4): 831 - 838.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
C. VAURS-BARRIÈRE, F. PENAULT-LLORCA, V. LAPLACE-MARIEZE, N. PRESNEAU, C. M MAUGARD, M. FICHE, A. HARDOUIN, and Y.-J. BIGNON
Low frequency of microsatellite instability in BRCA1 mutated breast tumours
J. Med. Genet., October 1, 2000; 37(10): 32e - 32.
[Full Text]


Home page
Am. J. Pathol.Home page
J. Lukas, N. Niu, and M. F. Press
p53 Mutations and Expression in Breast Carcinoma in Situ
Am. J. Pathol., January 1, 2000; 156(1): 183 - 191.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K.-A. Phillips, I. L. Andrulis, and P. J. Goodwin
Breast Carcinomas Arising in Carriers of Mutations in BRCA1 or BRCA2: Are They Prognostically Different?
J. Clin. Oncol., November 1, 1999; 17(11): 3653 - 3663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. E. Johnson, G. K. Kovvali, S. N. Guzder, N. S. Amin, C. Holm, Y. Habraken, P. Sung, L. Prakash, and S. Prakash
Evidence for Involvement of Yeast Proliferating Cell Nuclear Antigen in DNA Mismatch Repair
J. Biol. Chem., November 8, 1996; 271(45): 27987 - 27990.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Johnson, G. Kovvali, L Prakash, and S Prakash
Requirement of the yeast RTH1 5' to 3' exonuclease for the stability of simple repetitive DNA
Science, July 14, 1995; 269(5221): 238 - 240.
[Abstract] [PDF]


Home page
ScienceHome page
P. Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, S Tavtigian, L. Bennett, A Haugen-Strano, J Swensen, Y Miki, et al.
BRCA1 mutations in primary breast and ovarian carcinomas
Science, October 7, 1994; 266(5182): 120 - 122.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.